Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight

The neuromodulation devices market is expanding swiftly, propelled by the increasing global incidence of chronic conditions such as pain, epilepsy, and depression. This growth is further supported by ...

Valentine’s Day 2026 Wellness Gift Report: Nuropod Highlights Growing Interest in Vagus Nerve Stimulation Devices

As Valentine’s Day gifting trends continue to shift toward wellness-focused products, neuromodulation devices are ...
TMCnet

Study Confirms Safety of Using Theranica's Nerivio® REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices

Published in the Journal of Clinical Medicine, the study demonstrates that administering treatment of migraine with Remote Electrical Neuromodulation (REN) does not impact blood s ...
Nasdaq

ReShape Lifesciences® Secures Patent for Innovative Vagal Neuromodulation Device to Treat Type 2 Diabetes with Enhanced Energy Efficiency

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
MassDevice

Neuromod Devices reports positive Lenire tinnitus device data

Neuromod Devices today announced new data supporting the use of its Lenire tinnitus treatment device in U.S. patients.

Non-Invasive Vagus Nerve Stimulation Wearable Marks a Shift Toward At-Home Recovery Support Across the U.S.

At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...
Wane

SpineX’s Neuromodulation Technology Expands to Global Markets Through Partnership between Vivatronix and ImagineHealth

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...
Nasdaq

ReShape Lifesciences® Unveils Innovative Diabetes Neuromodulation Device Demonstrating Safe Glucose Modulation at Minnesota Neuromodulation Symposium

ReShape Lifesciences® announced the presentation of pre-clinical data for its innovative Diabetes Neuromodulation device at the Minnesota Neuromodulation Symposium. This device employs Hypoglycemia ...
Morningstar

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium

IRVINE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will present pre ...
Healio

Q&A: Neuromodulation device effective for drug-resistant focal epilepsy, 3-year data show

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...
National Academies of Sciences%2c Engineering%2c and Medicine

Non-Invasive Neuromodulation of the Central Nervous System: A Workshop

Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...